These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8787924)

  • 41. Antibacterial properties of AM-1155, a new 8-methoxy quinolone.
    Hosaka M; Kinoshita S; Toyama A; Otsuki M; Nishino T
    J Antimicrob Chemother; 1995 Aug; 36(2):293-301. PubMed ID: 8522459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antimicrobial activity of E-4441, a representative azetidine quinolone.
    Esteve M; Moros M; Coll R; Xicota MA; Llovera S
    Drugs Exp Clin Res; 1990; 16(9):445-9. PubMed ID: 2100245
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure-activity relationship of fluoroquinolone in Escherichia coli.
    Lee S; Park T; Lee Y
    Arch Pharm Res; 1998 Apr; 21(2):106-12. PubMed ID: 9875416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro comparison of E4868, a new trifluoroquinolone, with ciprofloxacin and temafloxacin tested against 5192 recent clinical isolates from five medical centers.
    Murray PR; Jones RN; Washington JA; Gerlach EH; Allen SD
    Diagn Microbiol Infect Dis; 1993; 17(4):307-11. PubMed ID: 8112046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro and in vivo antibacterial efficacies of CFC-222, a new fluoroquinolone.
    Kim JH; Kang JA; Kim YG; Kim JW; Lee JH; Choi EC; Kim BK
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2209-13. PubMed ID: 9333049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Susceptibility of vaginal bacteria to metronidazole and tinidazole.
    Austin MN; Meyn LA; Hillier SL
    Anaerobe; 2006; 12(5-6):227-30. PubMed ID: 16893662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 6-Aminoquinolones: a new class of quinolone antibacterials?
    Cecchetti V; Clementi S; Cruciani G; Fravolini A; Pagella PG; Savino A; Tabarrini O
    J Med Chem; 1995 Mar; 38(6):973-82. PubMed ID: 7699714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
    Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
    Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The in-vitro activity of trovafloxacin and nine other antimicrobials against 413 anaerobic bacteria.
    Bowker KE; Wootton M; Holt HA; Reeves DS; MacGowan AP
    J Antimicrob Chemother; 1996 Aug; 38(2):271-81. PubMed ID: 8877542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro and in vivo antibacterial activities of DW-224a, a new fluoronaphthyridone.
    Park HS; Kim HJ; Seol MJ; Choi DR; Choi EC; Kwak JH
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2261-4. PubMed ID: 16723601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Fluoroquinolones: importance, development of research, new drugs, questions for discussion].
    Padeĭskaia EN
    Antibiot Khimioter; 1998; 43(11):38-44. PubMed ID: 10079866
    [No Abstract]   [Full Text] [Related]  

  • 52. In-vitro and in-vivo antibacterial activity of CFC-222, a new fluoroquinolone.
    Kim JH; Choi KH; Kim JW; Lee JH; Choi EC; Kim BK
    J Antimicrob Chemother; 1998 Feb; 41(2):223-9. PubMed ID: 9533464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, antibacterial activity, and toxicity of 7-(isoindolin-5-yl)-4-oxoquinoline-3-carboxylic acids. Discovery of the novel des-F(6)-quinolone antibacterial agent garenoxacin (T-3811 or BMS-284756).
    Hayashi K; Takahata M; Kawamura Y; Todo Y
    Arzneimittelforschung; 2002; 52(12):903-13. PubMed ID: 12572531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The fluoroquinolones.
    Walker RC
    Mayo Clin Proc; 1999 Oct; 74(10):1030-7. PubMed ID: 10918871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone.
    Takahata M; Mitsuyama J; Yamashiro Y; Yonezawa M; Araki H; Todo Y; Minami S; Watanabe Y; Narita H
    Antimicrob Agents Chemother; 1999 May; 43(5):1077-84. PubMed ID: 10223917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
    Fernandes PB; Swanson RN
    Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bacteriological activity of trovafloxacin, a new quinolone, against respiratory tract pathogens.
    Pechère JC; Gootz TD
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):405-12. PubMed ID: 9758283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and structure-activity relationships of 7-diazabicycloalkylquinolones, including danofloxacin, a new quinolone antibacterial agent for veterinary medicine.
    McGuirk PR; Jefson MR; Mann DD; Elliott NC; Chang P; Cisek EP; Cornell CP; Gootz TD; Haskell SL; Hindahl MS
    J Med Chem; 1992 Feb; 35(4):611-20. PubMed ID: 1311762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [New fluoroquinolones: characteristics of antimicrobial effect and pharmacokinetics].
    Bondareva NS; Budanov SV
    Antibiot Khimioter; 1998; 43(8):28-33. PubMed ID: 9777103
    [No Abstract]   [Full Text] [Related]  

  • 60. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.